ClinConnect ClinConnect Logo
Search / Trial NCT05141916

Optimizing the Evaluation and Management of Patients With Suspected Choledocholithiasis

Launched by UNIVERSITY OF CALGARY · Nov 19, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the best ways to evaluate and manage patients who may have choledocholithiasis, which means stones in the common bile duct. This condition can lead to serious health problems if it's not treated properly. The trial is looking at different methods for diagnosing and deciding on treatment for patients who are suspected of having these stones, especially those who fall into an "intermediate risk" category. This group currently has limited options, often leading them to undergo a procedure called endoscopic retrograde cholangiopancreatography (ERCP), which is effective but comes with risks. Researchers are exploring whether looking at changes in liver enzymes could help improve the evaluation process for these patients.

To participate in this trial, individuals must be at least 18 years old and have suspected choledocholithiasis. They must also be able to give informed consent, meaning they understand what the trial involves. Those who have had previous treatments for choledocholithiasis or have certain other health conditions may not be eligible. Participants can expect to undergo additional tests that can help doctors better understand their condition and decide on the safest and most effective treatment. This research aims to improve the way doctors assess and treat patients with suspected bile duct stones, ultimately leading to better health outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with suspected choledocholithiasis, regardless of probability
  • age 18 years old or older
  • able to give informed consent to involvement (in the prospective validation phase).
  • Exclusion Criteria:
  • Unable or unwilling to provide informed consent;
  • age \< 18 years;
  • suspected or proven cholangitis;
  • previous ERCP with sphincterotomy;
  • prior diagnosis or management of choledocholithiasis;
  • outpatient status;
  • out-of-province status (prohibiting full medical record access).

About University Of Calgary

The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.

Locations

Calgary, Alberta, Canada

Patients applied

0 patients applied

Trial Officials

Nauzer Forbes, MD, MSc

Principal Investigator

University of Calgary

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials